Results 1 to 10 of about 49,507 (253)

Antithrombin III deficiency in a patient with recurrent venous thromboembolism: A case report. [PDF]

World J Clin Cases, 2023
BACKGROUND Antithrombin III (AT3) deficiency, an autosomal dominant disease, increases the likelihood of an individual developing venous thromboembolism (VTE). Long-term anticoagulation treatment is required for those suffering from AT3 deficiency.
Luo JQ, Mao SS, Chen JY, Ke XY, Zhu YF, Huang W, Sun HM, Liu ZJ.   +7 more
europepmc   +2 more sources

Antithrombin III deficiency-induced coagulopathy in the context of COVID-19: a case series. [PDF]

Br J Haematol, 2021
clearly presents minimal risk to confidentiality of study participants. We were to gain due to the patient’s death prior to collection of the data, only three indirect identifiers are included in the dataset (age, sex and body mass index) therefore ...
Gardner AJ, Kirkin DJ, Rodriguez-Villar S, Leoz Abellanas G, Tee A, Valentin A.   +5 more
europepmc   +2 more sources

Antithrombin III Deficiency [PDF]

Annals of Cardiac Anaesthesia, 2020
At the conclusion of this activity, pharmacists will be able to: • Describe inherited hypercoagulable states • Describe acquired hypercoagulable states • Apply management strategies for various hypercoagulable states including Anithrombin III Deficiency,
A. Tomar, M. Daga, Nitin Kaushik, Prem Kumar Singh   +3 more
openaire   +2 more sources

Successful treatment with rivaroxaban of an extended deep vein thrombosis complicated by pulmonary embolism in a patient with familial antithrombin III deficiency: a case report. [PDF]

Eur Heart J Case Rep, 2020
Background  Patients with low levels of antithrombin III (AT III) are at an increased risk of developing arteriovenous thromboembolic disease. Case summary  We report a case of a 28-year-old woman who presented with a 1-week history of spontaneous right ...
Appignani M, Sciartilli A, Caputo M, Di Girolamo E.   +3 more
europepmc   +2 more sources

Strategy for Cardiovascular Surgery in Patients with Antithrombin III Deficiency. [PDF]

Ann Thorac Cardiovasc Surg, 2018
Antithrombin III (ATIII) deficiency is a rare disorder in which thrombosis can be induced by stimuli that do not usually lead to thrombus formation, including minor injuries and surgery. Therefore, patients with ATIII deficiency undergoing cardiovascular
Nishimura Y, Takagi Y.
europepmc   +2 more sources

A case report of atrial fibrillation in a patient with heparin resistance associated with an antithrombin III deficiency successfully treated by radiofrequency catheter ablation using a direct thrombin inhibitor. [PDF]

Eur Heart J Case Rep, 2019
Background Pulmonary vein antrum isolation has proven to be a useful strategy for radiofrequency catheter ablation (RFCA) of atrial fibrillation (AF) worldwide.
Kang H, Takemoto M, Tayama KI, Kosuga KI.   +3 more
europepmc   +2 more sources

Edoxaban Was Effective for the Treatment of Deep Vein Thrombosis and Pulmonary Thromboembolism in a Cancer Patient with Antithrombin III Deficiency. [PDF]

Intern Med, 2016
A 57-year-old man with antithrombin III deficiency with deep vein thrombosis and pulmonary thromboembolism after surgery for colon cancer was managed with warfarin and inferior vena cava filtration.
Kawano H, Maemura K.
europepmc   +2 more sources

The unexpected clot: unilateral brachial artery occlusion unmasking antithrombin III deficiency; case report and therapeutic considerations [PDF]

Thrombosis Journal
Background Antithrombin III (AT III) deficiency is a rare autosomal dominant thrombophilia that typically predisposes carriers to venous thromboembolism.
Mohammad Ameen Ishqair, Amal A. Abu Jheasha, Anas Ameen Ishqair, Aliaa Khalili, Raed M. A. Isayed, Urwa A. M. Zarari   +5 more
doaj   +2 more sources

Antithrombin III deficiency and idiopathic intracranial hypertension: a case report [PDF]

Journal of Medical Case Reports
Background Idiopathic intracranial hypertension (IIH) is a condition where the pressure of the cerebrospinal fluid in the brain increases without a known cause.
Mansoureh Togha, Yousef Mokary, Elham Jafari   +2 more
doaj   +2 more sources

Familial Antithrombin III Deficiency

QJM: An International Journal of Medicine, 1982
SUMMARY Antithrombin III is the major physiological inhibitor of the coagulation mechanism and a deficiency of this protein results in a marked predisposition to venous thromboembolic disease. Three Scottish families with a deficiency of this protein are described and other reported families are reviewed.
J. Winter, A. Fenech, W. Ridley, B. Bennett, A. Cumming, Michael Mackie, A. Douglas   +6 more
openaire   +2 more sources